Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces onboarding of the 12th Center of Excellence in Spain, the La Paz University Hospital in Madrid, one of the most prestigious and world-leading hospitals.
Dr. Pablo Priego, Chief of the Esophagogastric and Bariatric Surgical Unit of La Paz University Hospital, and his team successfully completed the first two RefluxStop™ cases recently. As one of the most prestigious hospitals in the world and one of the largest in Spain, La Paz University is an influential teaching hospital well-known for its leadership in General and Digestive Surgery. The unit is managed by Dr. Constantino Fondevila, who supported the adoption of the RefluxStop™ procedure from the beginning.
Dr. Pablo Priego says, “It is exciting to be at the forefront of innovation in the surgical treatment of GERD and to make the RefluxStop™ procedure available to more patients. I’ve been seeking a surgical treatment for GERD that does not encircle the food passageway for many years, it’s thrilling to finally have this cutting-edge procedure to offer my patients who were not candidates for the traditional anti-reflux surgeries in the past.”
Dr. Peter Forsell, inventor of RefluxStop™, CEO and founder of Implantica, says, “Approximately 15% of the adult population in Spain suffer from GERD¹ with countless patients resigned to live with the painful symptoms because they are poorly treated by existing methods or not candidates for the mainstream anti-reflux surgical treatments.”
Dr. Forsell continues, “We are truly honored to see the world-leading hospitals, such as La Paz University Hospital, joining forces to bring the revolutionary RefluxStop™ technology to their GERD patients in Spain. Prof. Pablo Priego and his team want to deliver the most cutting-edge treatment for GERD, and we are supporting their critical work in Spain to address huge patient unmet need and bring relief to their GERD patients. Many patients have suffered for a long time and may have given up hope of a well working treatment for this often very painful disease.”
